2,709
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Cryptotanshinone possesses therapeutic effects on ischaemic stroke through regulating STAT5 in a rat model

, , , , , & show all
Pages 463-469 | Received 29 Apr 2020, Accepted 05 Apr 2021, Published online: 29 Apr 2021

References

  • Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. 2010. Cerebral autoregulation in stroke: a review of transcranial doppler studies. Stroke. 41(11):2697–2704.
  • Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo M-G. 2006. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 177(12):8338–8347.
  • Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. Embo J. 13(23):5605–5615.
  • Chen S, Wu H, Klebe D, Hong Y, Zhang J, Tang J. 2013. Regulatory T cell in stroke: a new paradigm for immune regulation. Clin Dev Immunol. 2013:689827.
  • Chen Z, Zhu R, Zheng J, Chen C, Huang C, Ma J, Xu C, Zhai W, Zheng J. 2017. Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma. Oncotarget. 8(30):50023–50033.
  • Dong B, Liang Z, Chen Z, Li B, Zheng L, Yang J, Zhou H, Qu L. 2018. Cryptotanshinone suppresses key onco-proliferative and drug resistant pathways of chronic myeloid leukemia by targeting STAT5 and STAT3 phosphorylation. Science China. 61:3–13.
  • Emsley CA, Hedley SJH. 2010. Post-stroke immunodepression and infection: an emerging concept. Infect Disord Drug Targets. 10(2):91–97.
  • Fei YX, Wang SQ, Yang LJ, Qiu YY, Li YZ, Liu WY, Xi T, Fang WR, Li YM. 2017. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 207:57–66.
  • Godebu E, Summers-Torres D, Lin MM, Baaten BJG, Bradley LM. 2008. Polyclonal adaptive regulatory CD4 Cells that can reverse type I diabetes become oligoclonal long-term protective memory cells. J Immunol. 181(3):1798–1805.
  • Halina O, Sandhya S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. 2006. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 26(5):654–665.
  • Hori S, Nomura T, Sakaguchi S. 2017. Pillars Article: Control of regulatory T cell development by the transcription factor FOXP3. Science 2003. 299: 1057-1061. J Immunol. 198(3):981–985.
  • Huang S, Chen G, Lu Y, Chen W. 2013. Molecular evidence of cryptotanshinone for treatment and prevention of human cancer. Anticancer Agents Med Chem. 13(7):979–987.
  • Hur JM, Shim JS, Jung HJ, Kwon HJ. 2005. Cryptotanshinone but not tanshinone IIA inhibits angiogenesisin in vitro. Exp Mol Med. 37(2):133–137.
  • Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF. 1999. Requirement for STAT5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol. 163(11):5971–5977.
  • Jing T, Xie-Hua X, Li-Dian C, Shan-Li Y, Min J, You-Liang G, Xiang-Bin W. 2010. Electroacupuncture improves neurological deficits and enhances proliferation and differentiation of endogenous nerve stem cells in rats with focal cerebral ischemia. Neurol Res. 32:198–204.
  • Kang BY, Chung SW, Kim SH, Ryu SY, Kim TS. 2000. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology. 49(3):355–361.
  • Keun-Sik H, Saver JL. 2010. Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke. 41(3):471–477.
  • Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T. 1991. Ischemic Tolerance' phenomenon detected in various brain regions. Brain Res. 561(2):203–211.
  • Li S, Wang H, Hong L, Liu W, Huang F, Wang J, Wang P, Zhang X, Zhou J. 2015. Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling. Cancer Biol Ther. 16(1):176–184.
  • Li S, Zhang G, Lou Z, Xu G, Zhang G. 2016. Cryptotanshinone sensitizes arsenic trioxide-induced Bel-7404 liver cancer cell apoptosis by downregulating phosphorylated-STAT3 in vitro and in vivo. Bmc Complem Altern M. 17:106–115.
  • Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. 2009. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 15(2):192–199.
  • Lo SH, Hsu CT, Niu HS, Niu CS, Cheng JT, Chen ZC. 2017. Cryptotanshinone inhibits STAT3 signaling to alleviate cardiac fibrosis in type 1-like diabetic rats. Phytother Res. 31(4):638–646.
  • Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20(1):84–91.
  • Lu L, Xiaohui Z, Julie W, Guo ZS, Hd A, Derya U. 2010. Characterization of protective human CD4+CD25+ FOXP3+ regulatory T cells generated with IL-2, TGF-β and retinoic acid. Plos One. 5(12):e15150.
  • McCombe PA, Read SJ. 2008. Immune and inflammatory responses to stroke: good or bad? Int J Stroke. 3(4):254–265.
  • Owen DL, Farrar MA. 2017. STAT5 and CD4+ T cell immunity. F1000Res. 6:32–42.
  • Pei J, You X, Fu Q. 2015. Inflammation in the pathogenesis of ischemic stroke. Front Biosci. 20:772–783.
  • Peng L, Yin J, Wang S, Ge M, Han Z, Wang Y, Zhang M, Xie L, Li Y. 2019. TGF-β2/Smad3 signaling pathway activation through enhancing VEGF and CD34 ameliorates cerebral ischemia/reperfusion injury after isoflurane post-conditioning in rats. Neurochem Res. 44(11):2606–2618.
  • Satoru I, Dragan M, Yongshan M, Ryo O, Christl R, Hallenbeck JM. 2009. Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 29(3):606–620.
  • Shekhar S, Cunningham MW, Pabbidi MR, Wang S, Booz GW, Fan F. 2018. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches. Eur J Pharmacol. 833:531–544.
  • Shimon S, Tomoyuki Y, Takashi N, Masahiro O. 2008. Regulatory T cells and immune tolerance. Cell. 133:775–787.
  • Sommer CJ. 2017. Ischemic stroke: experimental models and reality. Acta Neuropathol. 133(2):245–261.
  • Wang Y, Zhou C, Gao H, Li C, Li D, Liu P, Huang M, Shen X, Liu L. 2017. Therapeutic effect of cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation. Biochem Pharmacol. 138:119–129.
  • Yin HQ, Choi YJ, Kim YC, Sohn DH, Ryu SY, Lee BH. 2009. Salvia miltiorrhiza Bunge and its active component cryptotanshinone protects primary cultured rat hepatocytes from acute ethanol-induced cytotoxicity and fatty infiltration. Food Chem Toxicol. 47(1):98–103.
  • Zhu W, Qiu W, Lu A. 2017. Cryptotanshinone exhibits therapeutical effects on cerebral stroke through the PI3K/AKT‑eNOS signaling pathway. Mol Med Rep. 16(6):9361–9366.